Resident cardiac mast cells and ischemia - Reperfusion injury

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 8, Issue 2, 2003, Pages 135-148

  Singh, Manjeet ^a   Saini, Harjot K ^b  

^a PUNJABI UNIVERSITY   (India)

^b NONE

Author keywords

Cardiac mast cells; Cellular calcium; Ischemia reperfusion injury; Nitric oxide; p38 mitogen activated protein kinase; Phosphodiesterase; Preconditioning

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; 2',4' DICHLOROBENZAMIL; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADRENERGIC RECEPTOR BLOCKING AGENT; BENZAMIL; CALCIUM ANTAGONIST; CANAVANINE; CETIRIZINE; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; CYTOKINE; ENDOTOXIN; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PRAZOSIN; THEOPHYLLINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INFLAMMATION; LEUKOCYTE; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0038170601     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840300800207     Document Type: Review

References (266)

1. Ellis SG. Interventions in acute myocardial infarction. Circulation 81(Suppl IV):43, 1990
2. Topol EJ, Weiss JL, Guzman P, et al. Immediate improvement of dysfunctional myocardial segments after coronary vascularization: Detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol 4:1123, 1984
3. Fransen EJ, Maessen JG, Hermens WT, et al. Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary bypass graft patients. Cardiovasc Res 45:853, 2000
4. Leiboff RH, Katz RN, Wasserman AG, et al. A randomized angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol 53:404, 1984
5. Rentrop KP. Thrombolytic therapy in patients with acute myocardial infarction. Circulation 71:627, 1985
6. Braunwald E, Kloner RA. Myocardial reperfusion: A double edged sword? J Clin Invest 76:1713, 1985
7. Lucchesi BR. Complement neutrophils and free radicals: Mediators of reperfusion injury. Arzeimittel-Forschung 44:420, 1994
8. Grech ED, Jackson MJ, Ramsdale DR. Reperfusion injury after acute myocardial infarction. Br Med J 310:477, 1995
9. Mannings AS, Hearse DJ. Reperfusion induced arrhythmias: Mechanism and prevention. J Mol Cell Cardiol 16:497, 1984
10. Coombs VJ, Black L, Townsend SN. Myocardial reperfusion injury: The critical challenge. Crit Care Nurs Clin North Am 4:339, 1992
11. Bolli R. Mechanism of myocardial "stunning". Circulation 82:723, 1990
12. Hess ML, Kukreja RC. Free radicals calcium homeostasis, heat shock proteins and myocardial stunning. Ann Thorac Surg 60:760, 1995
13. Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: Pathogenesis and therapeutic implications. J Am Coll Cardiol 13:450, 1989
14. Steenbergen C, Hill ML, Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic and ischemic myocardium in vitro. Circ Res 57:864, 1985
15. 2+ homeostasis in pH paradox of reperfusion injury to neonatal rat cardiac myocytes. Am J Physiol 265:C129, 1993
16. Jennings RB, Ganote CE, Reimer KA. Ischemic tissue injury. Am J Pathol 81:179, 1975
17. Jennings RB, Hawkins HKK, Lowe JE, Hill MC, Reimer KA. Relation between high-energy phosphate and lethal injury in myocardial ischemia in dogs. Am J Pathol 92:187, 1978
18. Burton KP, Morris AC, Massey KD, et al. Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes. J Mol Cell Cardiol 22:1035, 1990
19. Korthuis RJ, Granger DN. Reactive oxygen metabolites, neutrophils and the pathogenesis of ischemic- tissue/reperfusion. Clin Cardiol 16 (Suppl 1):119, 1993
20. Ambrosio G, Villari B, Chiariello M. Calcium antagonists and experimental myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 20 (Suppl 7):S26, 1992
21. 2+ overload. J Cardiovasc Pharmacol 35:855, 2000
22. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia. J Am Coll Cardiol 11:1309, 1988
23. Entman ML, Smith CW. Post reperfusion inflammation: A model for reaction to injury in cardiovascular disease. Cardiovasc Res 28:1301, 1994
24. Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 71:226, 2001
25. Lucchesi BR, Mullane KM. Leukocytes and ischemia induced myocardial injury. Ann Rev Pharmacol Toxicol 26:201, 1986
26. Formigli L, Manneschi LI, Nediani C, et al. Are macrophages involved in early myocardial reperfusion injury? Ann Thorac Surg 71:1596, 2001
27. Keller AM, Clancy RM, Barr ML, et al. Acute reoxygenation injury in the isolated rat heart: Role of resident cardiac mast cells. Circ Res 63:1049, 1988
28. Parikh V, Singh M. Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 31:779, 1998
29. Lazarus B, Messina A, Barker JE, et al. The role of mast cells in ischemia and reperfusion injury in skeletal muscles. J Pathol 191:443, 2000
30. Mukundan C, Gurish MF, Austen KF, et al. Mast cell- mediation of muscle and pulmonary injury following hindlimb ischemia-reperfusion. J Histochem Cytochem 49:1055, 2000
31. Rydzynski K, Dalen H, Saetersdal T, Engadal H. Morphologic and morphometic analysis of mast cells from human heart biopsies. Agents Actions 20:288, 1987
32. Sperr WR, Bankl HC, Mundigler G, et al. The human cardiac mast cell: Localization, isolation, phenotype and functional characterization. Blood 84:3876, 1994
33. Marone G, de Crescenzo G, Adt M, et al. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 31:1, 1995
34. Patella V, de Crescenzo G, Ciccarelli A, et al. Human heart mast cells: A definitive case of mast cell heterogeneity. Int Arch Allergy Immunol 106:386, 1995
35. Irani AA, Schechter NM, Craig SS, et al. Two human mast cell subsets with distinct neutral protease compositions. Proc Natl Acad Sci USA 83:4464, 1986
36. Irani AA, Bradford TR, Kepley CL, et al. Detection of MC-T and MC-TC types of human mast cells by immunohistochemistry using new monoclonal antitryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509, 1989
37. Weidener N, Austen KF. Heterogeneity of mast cells at multiple sites. Path Res Pract 189:156, 1993
38. Flint KC, Leung KBP, Pearce FL, et al. Human mast cells recovered by bronchoalveolar lavage: Their morphology, histamine release and the effects of sodium cromoglycate. Clin Sci 68:427, 1985
39. Proctor GB, Chann KM, Garrett JR, Smith RE. Proteinase activity in bovine atrium and possible role of mast cell tryptase in the processing of atrial natriuretic factor. Comb Biochem Physiol 99:839, 1991
40. Compton SJ, Cairns JA, Holgate SJ, Walls AF. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161:1939, 1998
41. Urata H, Nishimura H, Ganten D. Mechanism of angiotensin II formation in humans. Eur Heart J 16:79, 1995
42. Daeman MJ, Urata H. Healing human myocardial infarction associated with increased chymase immunoreactivity. Heart Vessels 12 (Suppl):113, 1997
43. Wypij DM, Nichols JS, Navak PJ, et al. Role of mast cell chymase in the extracellular processing of big endothelin I to endothelin I in perfused rat lung. Biochem Pharmacol 43:845, 1992
44. Yurt RW, Leid RW Jr, Austen KF, Silbert JE. Native heparin from rat peritoneal mast cells. J Biol Chem 252:518, 1977
45. Pejler G, Karlstorm A. Thrombin is inactivated by mast cell secretory chymase. J Biol Chem 268:11817, 1993
46. Klein IM, Lavker RM, Matis WI, Murphy GK. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 86:8972, 1989
47. Walsh IJ, Trichieri G, Waldorf H, et al. Human dermal mast cells contain and release tumour necrosis factor-alpha which induces endothelial leukocyte adhesion molecule-1. Proc Natl Acad Sci USA 88:4220, 1991
48. Bankl HC, Radaszkiewicz T, Klappacher GW, et al. Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit-ligand. Circulation 91:275, 1995
49. Koskinen PK, Kovanen PT, Lindstedt KA, Lemstrom KB. Mast cells in acute and chronic rejection of rat cardiac allografts - a major source of basic fibroblast growth factor. Transplantation 71:1741, 2001
50. Zweifel M, Hirsiger H, Matozan K, et al. Mast cells in ongoing acute rejection: Increase in number and expression of a different phenotype in rat heart transplants. Transplantation 73:1707, 2002
51. Zong ZP, Matsui S, Li AL, et al. Growth hormone interferes with the progression of myocarditis in rats. Eur J Pharmacol 415:51, 2001
52. Patella V, Marino I, Arbustini E, et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97:971, 1998
53. Hara M, Ono K, Hwang MW, et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195:375, 2002
54. Cuculo A, Summaria F, Schiavino D, et al. Tryptase levels are elevated during spontaneous episodes in unstable angina but not after the ergonovine test in variant angina. Cardiologia 43:189, 1998
55. Laine P, Kaartinen M, Penttila A, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 99:361, 1999
56. Panizo A, Mirdan FJ, Galindo MF, et al. Are mast cells involved in hypertensive heart diseases? J Hypertens 13:1201, 1995
57. Norrby K. Mast cells and angiogenesis. APMIS 110:355, 2002
58. Jolly SR, Abrams GD, Romson JL, et al. Effects of lodoxamide on ischemic reperfused myocardium. J Cardiovasc Pharmacol 4:441, 1982
59. Frangogiannis NG, Lindsey ML, Michael LH, et al. Residual cardiac mast cell degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699, 1998
60. Schiller S, Dorfman A. The isolation of heparin from mast cells of normal rat. Biochem Biophys Acta 31:278, 1959
61. Nagata K, Fujimiya M, Sugiura H, Uehara M. Intracellular localization of serotonin in mast cells of the colon in normal and colitis rats. Histochem J 33:559, 2001
62. Henderson WR, Kaliner M. Mast cell granule peroxidase: Location, secretion and SRE-A inactivation. J Immunol 122:1322, 1979
63. Fukuishi N, Sakaguchi M, Matsuura S, et al. The mechanisms of compound 48/80-induced superoxide generation mediated by A-kinase in rat peritoneal mast cells. Biochem Mol Med 61:107, 1977
64. Henderson WR, Kaliner M. Immunologic and nonimmunologic generation of superoxide from mast cells and basophils. J Clin Invest 61:196, 1978
65. Galli SJ, Lichtenstein LM. Biology of mast cells and basophils. In Middleton EJ, Reed CE, Ellis EF (eds). Allergy: Principles and Practice. St Louis, Mosby, pp 106-134, 1988
66. Plaunt M, Pierce HJ, Watson CJ. Mast Cells lines produce lymphokines in response to cross linkage of FCeRI or to calcium ionophores. Nature 339:64, 1989
67. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/ cachectin. Nature 346:274, 1990
68. Gordon JR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 11:458, 1990
69. Teshima R, Onose J, Okunuki H, Sawada J. Effect of Ca (2+) ATPase inhibitors on MCP-1 release from bone marrow derived mast cells and the involvement of p38 MAPK activation. Int Arch Allergy Immunol 121:34, 2000
70. Tosaki A, Bagchi D, Hellegouarch A, et al. Comparison of ESR and HPLC methods for the detection of hydroxyl radicals in ischemic/reperfusion hearts. A relationship between the genesis of oxygen-free radicals and reperfusion induced arrythmias. Biochem Pharmacol 45:961, 1993
71. Kramer JH, Misik V, Weglicki WB. Lipid peroxidation-derived free radical production and postischemic myocardial reperfusion injury. Annal NY Acad Sci 723:180, 1994
72. Dhalla NS, Golfman L, Takeda S, et al. Evidence for the role of oxidative stress in acute ischemic heart disease: A brief review. Can J Cardiol 15:587, 1999
73. Grech ED, Dodd NJ, Jackson MJ, et al. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol 77:122, 1996
74. Gushchin I, Petyaev I, Tsinkalovesky O. Kinetics of oxygen metabolism indices in the course of histamine secretion from rat mast cell. Agents Actions 30:85, 1990
75. Wolfreys K, Oliviera D. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol 27:297, 1997
76. McNeill JH, Muschet LD. Histamine effects on cardiac contractility, phosphorylase and adenyl cyclase. J Mol Cell Cardiol 4:611, 1972
77. Schwartz LB, Metcalfe DD, Miller JS. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316:1622, 1987
78. Schwartz LB, Bradford TM. Regulation of tryptase from human lung mast cells by heparin stabilization of the active tetramer. J Biol Chem 261:7372, 1986
79. DelBalzo UH, Levi R, Polley MJ. Cardiac dysfunction caused by purified human C3a anaphylotoxin. Proc Natl Acad Sci USA 82:886, 1985
80. Pinkard RN, Olson MS, Gliclas PC, et al. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after myocardial infarction. J Clin Invest 56:740, 1975
81. McManus LM, Kolb WP, Crawford MH, et al. Complement localization in ischemic baboon myocardium. Lab Invest 48:346, 1983
82. Dabbous MK, Tipton DA, Haney L. Mast cell mediated stimulation of collagen degradation by gingival fibroblasts. J Dent Res 22:2005, 1987
83. Gruber BL, Schwartz LB, Ramamurthy NS, et al. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 140:3936, 1988
84. Venge R, Olsson I. Cationic proteins of human granulocytes. Effects on the complement system and mediation of chemotactic activity. J Immunol 115:1505, 1975
85. Seppa H, Vaananen K, Korhonen K. Effect of mast cell chymase of rat skin on intercellular matrix:a histochemical study. Acta Histochem 64:64, 1979
86. Mizutani, H, Schechter N, Lazarus G, et al. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821, 1991
87. Cain BS, Meldrum DR, Dinarello CA, et al. Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial functions. Crit Care Med 27:1309, 1999
88. Valen G, Kaszaki J, Szabo I, et al. Histamine release and its effects in ischemia-reperfusion injury of isolated rat heart. Acta Physiol Scand 150:413, 1994
89. Rona G, Chappel CI, Kahn DS. The significance of factors modifying the development of isoproternol induced myocardial infarction. Am heart J 66:389, 1963
90. Kantrowitz NE, Bristow MR, Minobe WA. Histamine mediated myocardial damage in rabbits. J Mol Cell Cardiol 14:551, 1982
91. Bristow MR, Ginsburg R, Harrison DC. Histamine and human heart: The other receptor system. Am J Cardiol 49:249, 1982
92. McNeill JH, Verna SC. Histamine receptors in rabbit heart. Proc West Pharmacol Soc 21:99, 1978
93. Ley K. Histamine can induce leukocyte rolling in rat mesenteric venules. Am J Physiol 267:H1017, 1994
94. Weyrich AS, Ma SL, Lefer AM. Protective effects of a P-selectin monoclonal antibody in myocardial ischemia and reperfusion. Circulation 86:180, 1992
95. Mathews N, Naele ML, Jackson SK, Stark JM. Tumor killing by tumor necrosis factor: Inhibition by anaerobic conditions, free radical scavengers and inhibitors of arachidonate metabolism. Immunology 62:153, 1987
96. Yamuchi N, Kuriyama H, Watanabe N, et al. Intracelllar hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 49:1671, 1989
97. Murphy HS, Shayman JA, Till GO. Superoxide responses of endothelial cells to C5a and TNF: Divergent signal transduction pathways. Am J Physiol 263:L 51, 1992
98. Pogrebniak HW, Mathews WA, Pass HI. Reactive oxygen species and amplify macrophage tumor necrosis factor production. Surg Forum 161:101, 1990
99. Maury CP, Teppo AM. Circulating tumor necrosis factor alpha (cachectin) in myocardial infarction. J Int Med 225:333, 1989
100. Squadrito F, Altavilla D, Zingarelli B, et al. Tumor necrosis factor involvement in myocardial ischemia reperfusion injury. Eur J Pharmacol 227:223, 1993
101. Patel VC, Yellon DM, Singh KJ, et al. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 194:234, 1993
102. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemia reperfusion injury. Cardiovasc Res 30:432, 1995
103. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocyte reduces their contractility in endotoxemia. Am J Physiol 263:H1963, 1992
104. Lamas S, Michel T, Brenner BM, Marsden PA. Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF. Am J Physiol 261:C634, 1991
105. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth cells. FEBS Lett 257:87, 1990
106. Oral H, Dorn GW, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-a in adult mammalian cardiac myocytes. J Biol Chem 272:4836, 1997
107. Ohta H, Yatomi Y, Sweeney EA, et al. Possible role of sphingosine induction of apoptosis by tumour necrosis factor-α in human neutrophils. FEBS Lett 355:267, 1994
108. 2 and sphingosine. Br J Pharmacol 124:493, 1998
109. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor alpha in the adult mammalian heart. J Clin Invest 92:2303, 1993
110. Arstall MA, Sawyer DB, Fukazowa R, Kelly RA. Cytokine mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85:829, 1999
111. Roberts LJ, Lewis RA, Oates JA, Austen KF. Prostaglandin, thromboxane and 12-hydroxy-5, 8,10,14-eicosatetraenoic acid production by ionophore stimulated rat serosal mast cells. Biochem Biophys Acta 575:185, 1979
112. Palmer RMJ, Stepney RJ, Higgs GA, Eakins KE. Chemokinetic activity of arachidonic acid lipoxygenase products on leukocytes of different species. Prostaglandins 20:411, 1980
113. Argenbright LW. Inflammatory mediators, cytokines and leukocyte adhesion in postcapillary venules. In Granger ND, Schmid-Schonbein WG (eds). Physiology and Pathophysiology of Leukocyte Adhesion. Oxford University Press, New York pp 171-185, 1995
114. Lindbom L, Hedqvist P, Dahler SE, et al. Leukotriene B4 induces extravasation and migration of polymorphonuclear leukocytes in vivo. Acta Physiol Scand 116:105, 1982
115. 2 release by leukotrienes in isolated guinea pig hearts. Eur J Pharmacol 73:357, 1981
116. 4 reduces coronary blood flow in the anesthetized dog. Prostaglandins 25:661, 1983
117. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion. Role of selectins. Circulation 98:1322, 1998
118. Frangogiannis NG, Perrard JL, Mendoza LH, et al. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98:687, 1998
119. Kubes P, Granger DN. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 32:699, 1996
120. Gaboury JP, Johnson B, Niu XF, Kubes P. Mechanisms underlying acute mast cell induced leukocyte rolling and adhesion in vivo. J Immunol 154:804, 1995
121. Ley K, Gachtgens P, Fennie C, et al. Lectin-like cell adhesion molecule mediates leukocyte rolling in mesenteric venules in vivo. Blood 77:2553, 1991
122. VonAndrian UH, Chambers JD, McEvoy LM, et al. Two step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA 88:7538, 1991
123. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 13:93, 1992
124. Patel KD, Lorant E, Jones DA, et al. Juxtacrine interactions of endothelial cells with leukocytes: Tethering and signaling molecules. Behring Inst Mitt 92:144, 1993
125. McPhail LC, DeChatelet LR, Shirley PS. Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest 58:774, 1976
126. Weiss SJ, Lamperts MB, Test ST. Long lived oxidants generated by human neutrophils: Characteristics and bioactivity. Science 222:625, 1983
127. Samuelsson B, Hammerstrom S, Murphy R, Borgeat P. Leukotrienes and slow reacting substance of anaphylaxis. Allergy 35:375, 1980
128. Lucchesi BR, Werns SW, Fentone JC. The role of neutrophils and free radicals in ischemic injury. J Mol Cell Cardiol 21:1241, 1989
129. Hara M, Matsumori A, Ono K, et al. Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 100:1443, 1999
130. Ing DJ, Zang J, Dzau V, et al. Modulation of cytokine induced cardiomyocyte apoptosis by nitric oxide, Bak and Bcl-x. Circ Res 84:21, 1999
131. Carswell EA, Old IJ, Kassel RL, et al. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666, 1975
132. Baxter GT, Kuo RC, Jupp OJN, et al. Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 274:9539, 1999
133. 2+ transients. FEBS Lett 376:24, 1995
134. Torre-Aminone G, Kapadia S, Lee J. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92:1487, 1995
135. 95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579, 1995
136. Lin Y, Devin A, Rodriguez Y, Liu Z. Cleavage of death domain kinase RIP by caspase-8 promotes TNF-induced apoptosis. Genes Dev 13:2514, 1999
137. Bradham CA, Qian T, Streetz K, et al. The mitochondrial transition is required for tumor necrosis factor apoptosis and cytochrome c release. Mol Cell Biol 18:6353, 1998
138. Qin H, Srinivascula SM, Wu G, et al. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor-1. Nature 399:549, 1999
139. Nicholson DW, Ali A, Thronberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
140. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP 32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81:801, 1995
141. Cohon GM. Caspases: The executioners of apoptosis. Biochem J 326:1, 1997
142. Black SC, Huang JQ, Rezaiefar P, et al. Colocalization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol 30:733, 1998
143. Yue TL, Wang C, Romanic AM, et al. Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. J Mol Cell Cardiol 39:495, 1998
144. Yaoita H, Ogawa K, Meehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97:276, 1998
145. Holly TA, Drincic A, Byun Y, et al. Caspase inhibition reduces myocyte cell death induced by ischemia and reperfusion in vivo. J Mol Cell Cardiol 31:1709, 1999
146. Yaoita H, Ogawa K, Meehara K, Maruyama Y. Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction. Cardiovasc Res 45:630, 2000
147. Panas D, Khadour FH, Szabo C, Schulz R. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide dependent mechanism. Am J Physiol 275:H101, 1998
148. Krown KA, Page MT, Nguyen C, et al. Tumour necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98:2864, 1996
149. Bielawska AE, Shapiro JP, Jiang L, et al. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol 151:1257, 1997
150. Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor-alpha induced apoptosis in cardiomyocytes: Involvement of sphingolipid signaling cascade in cardial cell death. J Clin Invest 98:2854, 1996
151. Hogaboam CM, Befus AD, Wallace JL. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet activating factor release. J Immunol 151:3767, 1993
152. Lee JC, Badger AM, Griswold DE, et al. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann NY Acad Sci 696:149, 1993
153. Kamitz LM, Abraham RT. Cytokine receptor signaling mechanisms. Curr Opin Immunol 7:320, 1995
154. Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac functions after myocardial ischemia and reperfusion. Circulation 99:1685, 1999
155. Barancik M, Htun P, Strohm C, et al. Inhibition of the cardiac p38-MAPK pathway by SB 203580 delays ischemic cell death. J Cardiovasc Pharmacol 35:474, 2000
156. Kimata M, Inagaki M, Kato T, et al. Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells. Biochem Pharmacol 60:589, 2000
157. Yue TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 82:166, 1998
158. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739, 1994
159. Quillet-Mary A, Jaffrezon JP, Mansat V, et al. Implication of mitochondrial hydrogen peroxide generation in ceramide induced apoptosis. J Biol Chem 272:21388, 1997
160. Maulik N, Yoshida T, Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Rad Biol Med 24:869, 1998
161. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs and ionizing radiations. FASEB J 7:361, 1993
162. Sandstorm PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum free medium. Proc Natl Acad Sci USA 90:4708, 1993
163. Li C, Browder W, Kao RL. Early activation of transcription factor NF-kB during ischemia in perfused rat heart. Am J Physiol 276:H543, 1999
164. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705, 1994
165. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 270:304, 1995
166. Nagata S. Apoptosis by death factor. Cell 88:355, 1997
167. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124, 1986
168. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in the rat heart. Am J Physiol 263:H1107, 1992
169. Liu GS, Thornton J, Van Winckle DM, et al. Protection against infarction afforded by preconditioning is mediated by A, adenosine receptors in rabbit heart. Circulation 84:350, 1991
170. Vahlhaus C, Schulz R, Post H, et al. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 79:407, 1996
171. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 82:609, 1990
172. Ikonomidis JS, Shirai T, Weisel RD, et al. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 272:H1220, 1997
173. 1B-adrenoceptors, pertusis toxin sensitive G proteins and protein kinase C. Circulation 92:2259, 1995
174. Tosaki A, Behjet N, Engelman DT, et al. Alpha-I adrenergic receptor induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther 273:689, 1995
175. Sharma A, Singh M. The possible role of adrenergic component in ischemic preconditioning. Meth Find Exp Clin Pharmacol 19:L 493, 1997
176. Goto M, Liu Y, Yang X, et al. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77:611, 1995
177. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A, selective adenosine analogues protects the heart against infarction. Circulation 85:659, 1992
178. Schultz JEJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78:1100, 1996
179. Hide EJ, Piper J, Thiemermann C. Endothelin-1-induced reduction of myocardial infarct size by activation of ATP- sensitive potassium channels in a rabbit model of myocardial ischemia and reperfusion. Br J Pharmacol 116:2597, 1995
180. Walker DM, Pasini E, Kucukoglu S, et al. Heat stress limits infarct size in the isolated perfused rabbit heart. Cardiovasc Res 27:962, 1993
181. Szekeres L, Papp GJ, Szilvassy Z, et al. Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res 27:593, 1993
182. Howard G, Geoghegan TE. Altered cardiac tissue gene expression during acute hypoxic exposure. Mol Cell Biochem 69:155, 1986
183. Shizukuda Y, Mallet RT, Lee S, Downey HF. Hypoxic preconditioning of ischemic canine myocardium. Cardiovasc Res 26:534, 1992
184. Tuijl MJ, Ven Bergenen Henegouwen PM, Van Wijk R, Verkleij AJ. The isolated neonatal rat cardiomyocyte used as in vitro model for ischemia: Induction of the 68kDa heat shock protein. Biochim Biophys Acta 1091:278, 1991
185. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning. A critical review. Cardiovasc Res 40:9, 1988
186. Kawata H, Yoshida K, Kawamoto A, et al. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Cir Res 88:696, 2001
187. Liu H, McPherson BC, Yao Z. Preconditioning attenuates apoptosis and necrosis: Role of protein kinase C epsilon and delta isoforms. Am J Physiol 281:H404, 2001
188. Xuan Y, Tang X, Banerjee S, et al. Nuclear factor-κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 84:1095, 1999
189. Baines CP, Wang L, Cohen MV, Downey JM. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 30:383, 1998
190. Vahlhaus C, Schulz R, Post H, et al. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 30:197, 1998
191. Yin T, Sandhu G, Wolfgang CD, et al. Tissue specific pattern of stress kinase activation in ischemic-reperfused heart and kidney. J Biol Chem 272:19943, 1997
192. Dana A, Skarli M, Papakrivopoulou J, Yellon DM. Adenosine A, receptor induced delayed preconditioning in rabbits: Induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase-and protein kinase C-dependent mechanism. Circ Res 86:989, 2000
193. Nakano A, Baines CP, Kim SO, et al. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: Evidence for involvement of p38 MAPK. Circ Res 86:144, 2000
194. Fryer RM, Eells JT, Hsu AK, et al. Ischemic preconditioning in rats: Role of mitochondrial KATP channel in preservation of mitochondrial function. Am J Physiol 278:H305, 2000
195. Nakai Y, Horimoto H, Mieno S, Sasaki S. Mitochondrial ATP-sensitive potassium channel plays a dominant role in ischemic preconditioning of rabbit
196. Barry WH. Calcium and ischemic injury. Trends Cardiovasc Med 1:162, 1991
197. 2+ channels. A possible mechanism of ischemic preconditioning. Cir Res 76:1049, 1995
198. Weiss RG, de Albuquerque CP, Vandegaer K, et al. Attenuated glycogenolysis reduced glycolytic catabolite accumulation during ischemia in ischemic preconditioned rat hearts. Circ Res 79:435, 1996
199. Lawson CS, Downey JM. Preconditioning: State of the art of myocardial protection. Cardiovasc Res 27:542, 1993
200. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66:913, 1990
201. + exchange inhibitor on cardioprotective effect of ischemic preconditioning: Possible involvement of resident cardiac mast cells. Pharmacol Res 36:95, 1997
202. Parikh V, Singh M. Resident cardiac mast cells and cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 30:149, 1997
203. Parikh V, Singh MP. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacol Res 40:129, 1999
204. Parikh V, Singh M. Possible role of nitric oxide and mast cells in endotoxin-induced cardioprotection. Pharmacol Res 43:39, 2001
205. Sharma A, Singh M. Molecular and cellular mechanism of cardioprotective effect of ischemic preconditioning. Thesis Punjabi University Patiala, India, 2001
206. 3 receptors: Pharmacological properties, species difference and receptor functions. Trends Pharmacol Sci 15:598, 1994
207. Wang P, Downey JM, Cohen MV. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 91:458, 1996
208. Humphreys RA, Kane KA, Parratt JR. Lack of involvement of mast cell degranulation in antiarrhythmic effect of preconditioning in rats. J Cardiovas Pharmacol 31:418, 1998
209. White JR, Ishizaka T, Ishizaka K, Shauji R. Direct demonstration of increase intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cells. Proc Natl Acad Sci USA 81:3978, 1984
210. Theoharides TC, Sieghart W, Cirengaard P, Douglas WW. An antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 207:80, 1980
211. Liao L, Granger DN. Role of mast cells in oxidised low-density lipoprotein induced microvascular dysfuction. Am J Physiol 271:H1795, 1996
212. Costa JJ, Harris AG, Delano FA, et al. Mast cell degranulation and parenchymal cell injury in the rat mesentery. Microcirculation 6:237, 1999
213. Jaggi AS, Sharma A, Singh M. Role of resident cardiac mast cells in ischemia-reperfusion induced myocardial injury. Thesis Punjabi University Patiala, India, 2000
214. DoBoer LVW, Nosta JJ, Johnson HG, Kloner RA. Reduction of myocardial infarct size by Lodoxamide (U-42-585E), a mast cell inhibitor (Abstract). Clin Res 29:A185, 1981
215. Queralt M, Brazis P, Merlos M, et al. In vitro inhibitory effect of rupatadine on histamine and TNF-α release from dispersed canine skin mast cells and the human mast cell line HMC-1. 49:355, 2000
216. Crivellato E, Candussioi L, Decorti G, et al. Adriamycin binds to the matrix of secretory granules during mast cell exocytosis. Biotech Histochem 72:111, 1997
217. Bristow MR, Sageman WS, Scott RH, et al. Acute and chronic cardiovascular effects of doxorubicin in the dog. The cardiovascular pharmacology of drug-induced histamine release. J Cardiovasc Pharmacol 2:487, 1980
218. Juniper EF, Cartier A, Trebilcock AL, et al. Effects of oxatomide compared with chlorpheniramine in allergic rhinoconjuctivitis. Clin Allergy 11:61, 1981
219. Masini E, Gianella G, Bianchi S, Mannaioni PF. Histamine and lactate dehydrogenase (LDH) release in ischemic myocardium of the guinea pig. Agents and Actions 20:281, 1987
220. Jacobi HH, Skov PS, Poulsen LK, et al. Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week pretreatment with intranasal azelastine or systemic cetirizine. J Allergy Clin Immunol 103:768, 1999
221. 1-histamine receptor antagonists in fluorescent imaging plate reader based calcium assays. J Biomol Screen 4:249, 1999
222. 1 antagonists on reaction-time performance in rats. Pharmacol Biochem Behav 70:427, 2001
223. Suresh PS, Sharma A, Singh M. Implication of H, receptors and resident cardiac mast cells in ischemia-reperfusion induced myocardial injury. Thesis Punjabi University Patiala, India, 2002
224. Schulze W, Fu ML. Localization of alpha 1-adrenoceptors in rat and human hearts by immunocytochemistry. Mol Cell Biochem 163-64:159, 1996
225. Exton JH. Molecular mechanisms involved in α adrenergic responses. Mol Cell Endocrin 23:233, 1981
226. Vanhoutte PM, Rimele TJ. Calcium and α adrenoceptors in activation of vascular smooth muscles. J Cardiovasc Pharmacol 4:S280, 1982
227. Kanno T, Cachrane DE, Dougas WW. Exocytosis (secretory granule extrusion) induced by injection of calcium into mast cells. Can J Physiol Pharmacol 51:1001, 1973
228. Foreman JC, Monger JL, Gompers BD. Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature 245:249, 1973
229. Moroni F, Fantozzi R, Masini E, Mannaioni PF. The modulation of histamine release by alpha-adrenoceptors: Evidences in murine neoplastic mast cells. Agents Actions 7:57, 1977
230. Nichols AJ, Sulpizio AC, Ashoton DJ, et al. In vitro pharmacologic profile of novel beta adrenoceptor antagonist and vasodilator cavedilol. Pharmacology 39:327, 1989
231. Cargnoni A, Claudio C, Bernocchi P, et al. Reduction of oxidative stress by carvedilol: Role of maintainance of ischemic myocardium viability. Circ Res 47:556, 2000
232. Book WM. Carvedilol: A nonselective beta blocking agent with antioxidant properties. Congest Heart Fail 8:173, 2002
233. Nichols AJ, Gellai M, Ruffolo RRJ. Studies on mechanism of arterial vasodilation produced by novel antihypertensive agonist carvedilol. Fund Clin Pharmacol 5:25, 1991
234. + exchange in cardiac physiology and pathophysiology: Mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 27:915, 1993
235. Ladzunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 17:1209, 1985
236. Meng HP, Lonsberry BR, Pierce GN. Influence of perfusate on the postischemic recovery of cardiac contractile function: Involvement of sodium hydrogen exchange. J Pharmacol Exp Ther 258:772, 1991
237. + exchange in cultured chick heart cells: Secondary stimulation of electrogenic transport during recovery from intracellular acidosis. J Mol Cell Cardiol 18:1109, 1986
238. + exchange. Circ Res 66:1156, 1990
239. Fossard N, Amella M, Landry Y. Sodium-potassium ATPase and immunological histamine release. Biochem Pharmacol 32:3259, 1983
240. Knudsen T, Bertelsen H, Johansen T. Ouabain enhancement of compound 48/80 induced histamine secretion from rat peritoneal mast cells: Dependence on extracellular sodium. Pharmacol Toxicol 70:412, 1992
241. + deplection of A23187-stimulated arachidonic acid and histamine release from rat mast cells. FEBS Lett 240:167, 1988
242. + exchange activity in purified canine cardiac sarcolemmal vesicles. J Biol Chem 260:4869, 1985
243. + exchange system in various cell types. Biochem Biophys Res Commun 116:86, 1983
244. + exchange inhibitor, on cardioprotective effect of ischemic and angiotensin preconditioning. Mol Cell Biochem 214:31, 2000
245. 2+ exchanger. Exp Neurol 145:38, 1997
246. Kamboj R, Sharma A, Singh M. Role of calcium in the cardioprotective effect of ischemic preconditioning. Thesis Punjabi University Patiala, India, 1999
247. Nayler WG, Poole-Wilson PA. Calcium antagonists definition and mode of action. Basic Res Cardiol 76:1, 1981
248. Ma J. Block by ruthenium red of ryanodine-activated calcium release channel of skeletal muscle. J Gen Physiol 102:1031, 1993
249. Ursell PC, Mayes M. Anatomic distribution of nitric oxide synthase in the heart. Int J Cardiol 50:217, 1995
250. Coleman JW. Nitric oxide: A regulator of mast cell activation and mast cell mediated inflammation. Clin Exp Immunol 129:4, 2002
251. Masini E, Gambassi F, Pistelli A, et al. Correlation between nitric oxide synthesis and histamine release in mast cells from spontaneously hypertensive rats: Influence of aging. Arch Allergy Immunol 99:404, 1992
252. Masini E, DiBello MG, Pistelli A, et al. Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J Physiol Pharmacol 45:41, 1994
253. Masini E, Bianchi S, Mugnal L, et al. The effect of nitric oxide generators on ischemia-reperfusion injury and histamine release in isolated perfused guinea pig heart. Agents Action 33:53, 1991
254. Mannaioni PF, Masini E. The release of histamine by free radicals. Free Rad Biol Med 5:177, 1988
255. Kubes P, Kanwar S, Niu X, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 7:1293, 1993
256. 2+ independent nitric oxide synthase in the myocardium. Br J Pharmacol 105:575, 1992
257. McKenna TM, Li S, Tsao S. PKC mediates LPS and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol 269:H1891, 1995
258. Song W, Furman BL, Parratt JR. Attenuation by dexamethasone of endotoxin protection against ischemia-induced ventricular arrhythmias. Br J Pharmacol 113:1083, 1994
259. Yang BC, Chen LY, Saldeen TG, Mehta JL. Reperfusion injury in the endotoxin-treated rat heart: Reevaluation if the role of nitric oxide. Br J Pharmacol 120:305, 1997
260. Iyenger R, Stuehr DJ, Marletta MA. Macrophage synthesis of nitrite, nitrate and N-nitrosamines: Precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84:6369, 1987
261. Shichijo M, Inagaki N, Kimata M, et al. Role of 3'-5'-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. J Allergy Clin Immunol 103:S421, 1999
262. Dent G, Giembycz MA, Evans PM, et al. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: Interaction with beta adrenoceptor agonist albuterol. J Pharmacol Exp Ther 271:1167, 1994
263. Paleman RA, Kips JC, Pauwels RA. Therapeutic activities of theophylline in chronic obstructive pulmonary disease. Clin Exp Allergy 28(Suppl 3):53, 1998
264. Brzezinska-Blaszczyk E, Forczmanski M, Pletrazak A. The action of tumor necrosis factor-alpha on rat mast cells. J Interferon Cytokine Res 20:377, 2001
265. Saini HK, Sharma A, Singh M. Resident cardiac mast cells and ischemia-reperfusion induced apoptotic and necrotic myocardial cell death. Thesis Punjabi University Patiala, India, 2002
266. Takahashi S, Keto Y, Fujita T, et al. FR 167653, a p38 mitogen activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils. J Pharmacol Exp Ther 296:48, 2001